Search

Sartorius Stedim Biotech.

Closed

SectorFinance

182.2 -1.14

Overview

Share price change

24h

Current

Min

178.9

Max

185.9

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

60.266

21.473

EPS

1.25

Dividend yield

0.39

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+23.99% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.39%

4.33%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

115M

18B

Previous open

183.34

Previous close

182.2

News Sentiment

By Acuity

76%

24%

398 / 437 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

17 Aug 2026, 23:56 UTC

News
Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

17 Aug 2026, 23:56 UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

17 Aug 2026, 23:56 UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

17 Aug 2026, 23:56 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

17 Aug 2026, 23:46 UTC

Correlated Moves
News

ManpowerGroup Inc shares are lower in after-market hours amid concerns over declining sales and profitability, with operating margins reported at just 1.5%.

17 Aug 2026, 23:46 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI offerings, contributing to shares trading roughly flat in after-hours activity.

17 Aug 2026, 23:41 UTC

News

Coherus BioSciences announced a special dividend of contingent value rights, boosting shares in after-market trading following the company's strategic asset sale initiative.

17 Aug 2026, 23:41 UTC

News
Social Media

XP Inc shares are lower in after-market hours after announcing a share cancellation and reporting mixed Q2 results, including adjusted net profit above estimates.

17 Aug 2026, 23:36 UTC

News

Whirlpool Corp is identified as a sell by Yahoo Finance amid concerns over declining sales and profitability. Shares are trading lower in after-market hours.

17 Aug 2026, 23:36 UTC

News

Enovix Corp shares are rising in after-market trading, rebounding from recent lows amid leadership changes and broader market declines for the Dow and S&P 500.

17 Aug 2026, 23:31 UTC

News

Fred Stephan named President and CEO effective November 1, 2026.

17 Aug 2026, 23:31 UTC

News

Zeta Global shares are lower in after-market hours, despite positive coverage highlighting strong performance and anticipated revenue growth of 25.1%.

17 Aug 2026, 23:21 UTC

News

AT&T Inc. shares are higher in after-market trading following a successful €1.2 billion and $1.1 billion notes issuance to enhance liquidity and capital structure.

17 Aug 2026, 23:16 UTC

News

Patterson-UTI Energy highlighted in Yahoo Finance cautionary analysis

17 Aug 2026, 23:16 UTC

Social Media
News

Wendy's Co. shares are lower in after-market hours following the announcement of President Pete Suerken's resignation and a restructuring plan.

17 Aug 2026, 23:16 UTC

News

Valero Energy shares are higher in after-market hours following analyst upgrades and price target increases amid rising crude oil prices linked to Middle East tensions.

17 Aug 2026, 23:11 UTC

News

Nasdaq Inc plans to extend U.S. trading hours to nearly 23 hours daily starting December 6, 2026, pending regulatory approval. Shares are higher in after-market trading.

17 Aug 2026, 23:06 UTC

News

DigitalOcean Holdings Inc. launched Managed AI Agents via Cloudways, contributing to shares trading higher after the market closed.

17 Aug 2026, 23:01 UTC

News

Mitek Systems appoints Aaron Seyler as Chief Revenue Officer, effective August 17, 2026. Shares are trading higher in after-market hours.

17 Aug 2026, 23:01 UTC

News

CACI awarded a contract worth up to $981 million with the U.S. Space Force, yet shares are trading lower in after-market hours.

17 Aug 2026, 23:01 UTC

News

Targa Resources has secured long-term midstream agreements with ExxonMobil and plans to invest $5 billion in new projects, driving shares higher in after-market trading.

17 Aug 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

17 Aug 2026, 23:01 UTC

News

Science Applications International Corp is under scrutiny after being flagged by Yahoo Finance. Shares are lower in after-hours trading following concerns over revenue projections.

17 Aug 2026, 23:01 UTC

Correlated Moves
News
Social Media

iShares 20+ Year Treasury Bond ETF gains in after-market trading, reflecting market sentiment influenced by rising crude oil prices amid geopolitical tensions.

17 Aug 2026, 23:01 UTC

News
Correlated Moves

BlackRock Inc shares declined in after-market trading, continuing a trend of lower daily closes amid geopolitical tensions and rising crude oil prices.

17 Aug 2026, 22:56 UTC

Correlated Moves
News

Kulicke and Soffa Industries shares are lower in after-market trading following the announcement of Dr. Raj Talluri as the new CEO, effective September 2026.

17 Aug 2026, 22:56 UTC

News

ComEd allocates over $170,000 to enhance public safety in 24 Illinois communities through its Powering Safe Communities Program. Exelon shares are higher in after-market trading.

17 Aug 2026, 22:51 UTC

Social Media
News

Kura Oncology shares rose in after-market trading after CEO Troy Wilson's $1.11 million stock purchase and positive earnings report highlighting $9.1 million in revenue.

17 Aug 2026, 20:07 UTC

News

Levi Strauss faces analyst skepticism over revenue performance and cash flow margins. The consensus price target is $28.27, implying a potential return of 26.2%.

17 Aug 2026, 20:07 UTC

News
Correlated Moves

The iShares 7-10 Year Treasury Bond ETF is trading lower amid rising 10-year Treasury yields and geopolitical tensions affecting economic growth and inflation expectations.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

23.99% upside

12 Months Forecast

Average 230 EUR  23.99%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

4

Buy

1

Hold

0

Sell

Sentiment

By Acuity

398 / 437 Finance

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat